Free Trial

Merit Medical Systems (MMSI) Stock Price, News & Analysis

$92.36
+0.41 (+0.45%)
(As of 11:21 AM ET)
Today's Range
$91.95
$92.99
50-Day Range
$80.71
$91.95
52-Week Range
$62.58
$92.99
Volume
89,813 shs
Average Volume
448,720 shs
Market Capitalization
$5.37 billion
P/E Ratio
53.08
Dividend Yield
N/A
Price Target
$97.10

Merit Medical Systems MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
5.1% Upside
$97.10 Price Target
Short Interest
Healthy
4.78% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.16
Upright™ Environmental Score
News Sentiment
0.00mentions of Merit Medical Systems in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$1.68 M Sold Last Quarter
Proj. Earnings Growth
10.94%
From $3.29 to $3.65 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.08 out of 5 stars

Medical Sector

130th out of 924 stocks

Surgical & Medical Instruments Industry

23rd out of 97 stocks

MMSI stock logo

About Merit Medical Systems Stock (NASDAQ:MMSI)

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

MMSI Stock Price History

MMSI Stock News Headlines

Massive Crypto Selloff = Historic Opportunity
Stocks recently suffered the worst 1-day loss since 2022… Cryptos got hammered as well…But here's the fact everyone is missing… As of this writing, Bitcoin is still up 28% year to date…And it's up 84% in the last year.
Massive Crypto Selloff = Historic Opportunity
Stocks recently suffered the worst 1-day loss since 2022… Cryptos got hammered as well…But here's the fact everyone is missing… As of this writing, Bitcoin is still up 28% year to date…And it's up 84% in the last year.
Merit Medical Systems Q2 Profit Rises; Lifts FY24 Outlook
Merit Medical Systems: Steady Wins The Day
See More Headlines
Receive MMSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/30/2024
Today
8/22/2024
Next Earnings (Estimated)
10/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:MMSI
CUSIP
58988910
Employees
6,950
Year Founded
1987

Price Target and Rating

Average Stock Price Target
$97.10
High Stock Price Target
$125.00
Low Stock Price Target
$87.00
Potential Upside/Downside
+5.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
11 Analysts

Profitability

Net Income
$94.41 million
Pretax Margin
9.42%

Debt

Sales & Book Value

Annual Sales
$1.30 billion
Cash Flow
$5.30 per share
Book Value
$20.81 per share

Miscellaneous

Free Float
55,956,000
Market Cap
$5.37 billion
Optionable
Optionable
Beta
0.88

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

MMSI Stock Analysis - Frequently Asked Questions

How have MMSI shares performed this year?

Merit Medical Systems' stock was trading at $75.96 at the start of the year. Since then, MMSI stock has increased by 21.6% and is now trading at $92.36.
View the best growth stocks for 2024 here
.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) issued its earnings results on Tuesday, April, 30th. The medical instruments supplier reported $0.77 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $0.06. The company's revenue for the quarter was up 8.7% on a year-over-year basis.

What is Fred P. Lampropoulos' approval rating as Merit Medical Systems' CEO?

158 employees have rated Merit Medical Systems Chief Executive Officer Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among the company's employees.

Does Merit Medical Systems have any subsidiaries?

Merit Medical Systems subsidiaries include Fibrovein Holdings Limited, Brightwater Medical Inc., Vascular Insights LLC, Cianna Medical Inc., DFINE Inc., BioSphere Medical SA, Alveolus Inc., and more.

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' top institutional shareholders include William Blair Investment Management LLC (5.25%), Conestoga Capital Advisors LLC (3.87%), Dimensional Fund Advisors LP (2.25%) and Westwood Holdings Group Inc. (1.33%). Insiders that own company stock include Fred P Lampropoulos, A Scott Anderson, Joseph Wright, F Ann Millner, Thomas James Gunderson, Ronald Frost, Neil Peterson, Raul Jr Parra, Brian G Lloyd, Lynne Ward, Michel James Voigt and Jill Anderson.
View institutional ownership trends
.

How do I buy shares of Merit Medical Systems?

Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET) and RTI Surgical (RTIX).

This page (NASDAQ:MMSI) was last updated on 8/22/2024 by MarketBeat.com Staff

From Our Partners